Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects

References

• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, . Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996;120:803–12.
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, . Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–9.
   PubMed Web of Science ®Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, . Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.
   Google Scholar
• Stefan N, Stumvoll M. Adiponectin—its role in metabolism and beyond. Horm Metab Res. 2002;34:469–74.
   PubMed Web of Science ®Google Scholar
• Santaniemi M, Kesäniemi YA, Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol. 2006;155:745–50.
   PubMed Web of Science ®Google Scholar
• Sung S, Chuang S, Sheu W, Lee W, Chu P, Chen C. Adiponectin, but not leptin or high-sensitivity C-reactive protein, is associated with blood pressure independently of general and abdominal adiposity. Hypertens Res. 2008;31:633–40.
   PubMedGoogle Scholar
• Wang ZV, Scherer PE. Adiponectin, cardiovascular function, and hypertension. Hypertension. 2008;51:8–14.
   PubMed Web of Science ®Google Scholar
• Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009;6:27–35.
   PubMedGoogle Scholar
• Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, . Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10:1384–9.
   PubMed Web of Science ®Google Scholar
• Maia-Fernandes T, Roncon-Albuquerque R Jr, Leite-Moreira AF. Cardiovascular actions of adiponectin: pathophysiologic implications. Rev Port Cardiol. 2008;27:1431–49.
   PubMedGoogle Scholar
• Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–52.
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;323:1706–7.
   PubMedGoogle Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med. 1989;110:101–7.
   PubMed Web of Science ®Google Scholar
• Cavusoglu E, Chopra V, Battala V, Ruwende C, Yanamadala S, Eng C, . Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography. Am J Cardiol. 2008;101:1073–8.
   PubMedGoogle Scholar
• Ebinç H, Ebinç FA, Ozkurt ZN, Doğru MT, Tulmaç M, Yilmaz M, . Impact of adiponectin on left ventricular mass index in non-complicated obese subjects. Endocr J. 2008;55:523–8.
   PubMed Web of Science ®Google Scholar
• Kozakova M, Muscelli E, Flyvbjerg A, Frystyk J, Morizzo C, Palombo C, . Adiponectin and left ventricular structure and function in healthy adults. J Clin Endocrinol Metab. 2008;93:2811–8.
   PubMedGoogle Scholar
• Top C, Sahan B, Onde ME. The relationship between left ventricular mass index and insulin sensitivity, postprandial glycaemia, and fasting serum triglyceride and adiponection levels in patients with type 2 diabetes. J Int Med Res. 2007;35:909–16.
   PubMedGoogle Scholar
• Hong SJ, Park CG, Seo HS, Oh DJ, Ro YM. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press. 2004;13:236–42.
   PubMed Web of Science ®Google Scholar
• Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesäniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999;245:163–74.
   PubMed Web of Science ®Google Scholar
• Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863–71.
   Google Scholar
• Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–83.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Gampo E, Sachs I, . Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.
   PubMed Web of Science ®Google Scholar
• Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R, . Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hyper-tensive patients. Am J Hypertens. 2005;18:30–5.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl. 2005;6:7–14.
   PubMed Web of Science ®Google Scholar
• Bełtowski J, Jamroz-Wiśniewska A, Widomska S. Adiponectin and its role in cardiovascular diseases. Cardiovasc Hematol Disord Drug Targets. 2008;8:7–46.
   PubMedGoogle Scholar
• Nishida M, Funahashi T, Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol. 2007;40:55–67.
   PubMed Web of Science ®Google Scholar
• Shinmura K, Tamaki K, Saito K, Nakano Y, Tobe T, Bolli R. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation. 2007;116:2809–17.
   PubMedGoogle Scholar
• Blake J, Devereux RB, Herrold EM, Jason M, Fisher J, Borer JS, . Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension. Am J Cardiol. 1988;62:246–52.
   PubMed Web of Science ®Google Scholar